Pharmocogenomics fails to address diseases in developing countries
Washington: A new study has revealed that despite of various promises made by international scientific community pharmacogenomic, only a few studies have been done on the rare, orphan and tropical diseases in developing countries.
According to the research done by Catherine Olivier, from University of Montreal's School of Public Health, from 1997 to 2003, there were 401 publications on pharmacogenomics identified in the PubMed database and 67 percent of them were published in a single journal, Pharmacogenetics.
Though the number of studies doubled in 2003 to 2010, the apparent enthusiasm for this type of research seems to have been artificially inflated.
Olivier said that the number of original articles, that is, studies focusing on a new aspect of pharmacogenomics, began to decline after 2002 and nearly 23 percent of published studies in pharmacogenomics dealt with the area of oncology, while 14.7 percent dealt with depression and psychological disorders and 13.6 percent was about cardiovascular disorders.
The findings were published in the journal Global Public Health.
More from India
More from World
More from Sports
More from Entertaiment
- UP CM Yogi Adityanath takes 50 decisions without single Cabinet meet
- Triple talaq, polygamy integral part of Islam: AIMPLB tells SC
- Triple Talaq: Why AIMPLB are opposing the petitions filed in Supreme Court?
- DNA: Should strict action be taken against stone pelters of J&K?
- Legal, illegal slaughterhouses in UP: What you need to know
- Kapil Sharma–Sunil Grover fallout: Kiku Sharda finally breaks silence
- Chinese national insults Indian flag, throws it in dustbin outside Noida Oppo office; massive protest takes place
- Left to die on road, pregnant Lucknow woman writes to PM Narendra Modi to end 'triple talaq', says 'I voted for BJP'
- Here's why Donald Trump called PM Narendra Modi
- Gautam Gambhir gives Aussies perfect send-off, says true champions let their game do all the talking!